Twist Bioscience Corp

CRISPR Therapeutics

Recursion Pharmaceuticals

Veracyte

Natera

CareDx

Adaptive Biotechnologies

Guardant Health Inc

Beam Therapeutics

Schrodinger 

ARK Genomic Revolution Multi-Sector ETF

ARKG is an actively managed fund that targets companies involved in the genomics industry.

Amplify Online Retail ETF

Sprott Gold Miners ETF

WisdomTree Cloud Computing Fund

Wall Street has been performing impressively with the major indices climbing to a 12-week high. The rally was mainly powered by optimism over a potential coronavirus vaccine as well as an uptick in the economic activities as lockdown measures loosen.

5 ETFs Up More Than 20% in Three Months

The ARK Genomic Revolution Multi-Sector ETF (NYSEArca: ARKG) fund may focus on biotechnological advances, but it’s been delivering freak of nature-like returns as of late. With ARKG up over 40% YTD despite the pandemic sell-off in March, it’s been a stellar performer and one that exchange-traded fund (ETF) investors need to watch as the economies [.

This Genomics ETF is Performing Like a Freak of Nature

VanEck Vectors Biotech ETF

First Trust NYSE Arca Biotechnology Index Fund

iShares Nasdaq Biotechnology ETF

SPDR S&P Biotech ETF

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

Biotech ETFs Soaring on COVID-19 Vaccine Progress

Global X Genomics & Biotechnology ETF

The scramble to bring a coronavirus vaccine to market is lifting the health care sector this year as a slew of biotechnology and other, more nuanced exchange-traded funds targeting the group are delivering impressive returns.

3 Genomics ETFs Worth Jumping For

iShares Genomics Immunology and Healthcare ETF

Invesco Dynamic Biotechnology & Genome ETF

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

Profit from the Genomics Market Momentum With These ETFs

The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is establishing a reputation for being one of the best-performing healthcare ETFs, a legacy forged over its multi-year lifespan, not just a few weeks. One of the driving forces behind ARKG’s enviable long-term track records its the manager’s ability to identify disruptive forces in the healthcare and [.

Power of Precision Medicine Could be Fueled Here

KraneShares MSCI All China Health Care Index ETF

Invesco DWA Healthcare Momentum ETF

The best Healthcare ETFs for Q3 2020 are ARKG, KURE, and PTH.

Best-Performing Healthcare ETFs for Q3 2020

ARK Genomic Revolution Multi-Sector ETF: An Overbought But Promising Niche Play

Virtus LifeSci Biotech Clinical Trials ETF

Principal Healthcare Innovators Index ETF

Something's been brewing in the health care sector, the second-largest group in the S&P 500.

3 Biotech ETFs Up 10% Or More Over The Last Month

The coronavirus pandemic is stirring renewed interest in healthcare investments, including ETFs. While the sector – the second-largest in the S&P 500 – is expansive, not all of its ETFs offer COVID-19 leverage.

Virus Detection Is Just One Catalyst for This Hot Genomics ETF

iShares U.S. Healthcare Providers ETF

Invesco S&P SmallCap Health Care ETF

ALPS Medical Breakthroughs ETF

SPDR S&P Health Care Equipment ETF

Health Care Select Sector SPDR Fund

Don't ignore healthcare stocks because 2020 is an election year. Some of these funds are poised for big upside.

7 of the Best Healthcare ETFs to Purchase for 2020

Pacer Financial has filed for Pacer BioThreat ETF to enjoy the first-mover advantage that provide investors an option to capitalize on the new opportunities triggered by coronavirus.

First-Mover Pandemic Disease Fight ETF On The Way

The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is already trouncing basic biotechnology and healthcare ETFs and historical data suggest that even if a recession lingers, ARKG could prove durable.

This Biotechnology ETF Could Be the Place to Be in a Recession

For healthcare investors in 2020, the genomics space has been the place to be, that is if they’ve been utilizing the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). Year-to-date, ARKG is higher by 15%, or better than triple the performance of the Nasdaq Biotechnology Index.

Big Growth Awaits a Golden Genomics ETF

The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) jumped more than 12 last week, but that’s not the only fun fact about the genomics ETF. Somewhat quietly, ARKG is flirting with its 52-week high.

This Genomics ETF Is up to Its Old Tricks and That’s Great For Investors

InfraCap MLP

ARK Innovation ETF

VanEck Vectors Gaming ETF

iShares MSCI Global Gold Miners ETF

Global X Silver Miners ETF

Vesper U.S. Large Cap Short-Term Reversal Strategy ETF

Volshares

The stabilization in the spread of the disease, hopes for re-opening of the economy anytime soon, and increased progress of drugmakers' to develop COVID-19 treatment has boosted confidence in the stock market.

10 ETFs Up More Than 30% in a Month

As the healthcare sector evolves and becomes more innovative, investors may be left yearning for more traditional approaches to the group.

Why This Healthcare ETF Matters Now

When it comes to the next generation of healthcare, genomics is one industry that’s engineering seismic shifts in the usually placid sector and the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is one of the ETFs driving that change. ARKG includes companies that merge healthcare with technology and capitalize on the revolution in genomic sequencing.

This ETF Welcomes Investors to the Next Generation of Healthcare

Genomics is one of the most disruptive technologies out there, one that is becoming more accessible due to declining costs.

How to View Assets and Liabilities in the Genomics Space

Aytu BioScience

Loncar Cancer Immunotherapy ETF

Co-Diagnostics

Forty Seven Inc

Vir Biotechnology

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

Coronavirus Scare Supports These Biotech ETFs & Stocks

Rarely a group lacking for compelling story lines, genomics stocks and exchange traded funds are receiving more attention due to the novel coronavirus epidemic, one that has put the spotlight on the next generation of healthcare.

This Genomics ETF’s Holdings Can Ward Off Chinese Competition

ARK Fintech Innovation ETF

ARK Industrial Innovation ETF

ARK Web x.0 ETF

As technology advance and markets try to seek out the next big thing, investors can consider exchange traded funds that focus on disruptive innovations to potentially capitalize on growing themes that could pervade the global economy.

ETFs to Tap into Disruptive Technologies That Can Revolutionize the World

There are areas of the burgeoning disruptive technologies space where investors may want to evaluate active management and genomics is one of those segments.

Smaller Names Prove Potent For This Genomics ETF

Davis Select Worldwide ETF

Emerging Markets Internet & Ecommerce ETF

ROBO Global Robotics and Automation ETF

US markets have experienced one of the greatest periods of performance relative to most broad asset classes over the last decade.

From FAANG to MAGA: The Acronym Soup Decade of US Large Cap Growth-ish Tech-ish Stocks

The race is on to find a cure for the deadly coronavirus and that competition could benefit some ETFs, including the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG).

News for ARK Genomic Revolution Multi-Sector ETF ETF (ARKG)